CRVS earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Buy, P/E -25.44. Updated 2026-07-23.
Corvus Pharmaceuticals (CRVS) Research Hub
Corvus Pharmaceuticals (CRVS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 12.91 USD (-3.15%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -25.44, market cap 1.17B. This hub links to the full technical, earnings and options research available for CRVS.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 12.91 USD (-3.15%) |
| 52-week range | 11.82 USD – 16.47 USD |
| Trend regime | Range |
| 14-day RSI | 41.5 (Bearish) |
| Trailing P/E | -25.44 |
| Market cap | 1.17B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for CRVS
Covered Call on CRVS: how it works, illustrative setup around the real 12.91 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CRVS: how it works, illustrative setup around the real 12.91 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CRVS: how it works, illustrative setup around the real 12.91 USD price, max profit/loss, breakeven and when to use it. Educational.
CRVS technical analysis: range, last 12.91 USD, RSI 41.5, 52w range 11.82 USD–16.47 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CRVS in?
Corvus Pharmaceuticals (CRVS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CRVS in an uptrend or downtrend?
As of 2026-09-11, CRVS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CRVS's trailing P/E ratio?
CRVS's trailing P/E is -25.44, with a market cap of 1.17B. See the earnings research page for full valuation detail.
When does CRVS next report earnings?
CRVS is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.17 USD.